SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-012764
Filing Date
2022-02-07
Accepted
2022-02-07 16:00:19
Documents
15
Period of Report
2022-02-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm225702d1_8k.htm   iXBRL 8-K 30481
2 EXHIBIT 10.1 tm225702d1_ex10-1.htm EX-10.1 85304
3 EXHIBIT 99.1 tm225702d1_ex99-1.htm EX-99.1 10308
7 GRAPHIC tm225702d1_ex99-1img001.jpg GRAPHIC 8105
  Complete submission text file 0001104659-22-012764.txt   339117

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA axla-20220207.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20220207_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20220207_pre.xml EX-101.PRE 22605
9 EXTRACTED XBRL INSTANCE DOCUMENT tm225702d1_8k_htm.xml XML 3593
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 22597340
SIC: 2836 Biological Products, (No Diagnostic Substances)